Dr. Sameer Khatri

Practising Since : 1999
91 9810381883 / 011 33669999

Dr. Sameer Khatri, based in New Delhi, is a Senior Consultant in Medical Oncology. He has an MBBS and a postgraduate MD degree in General Medicine from the Maulana Azad Medical College and associated Lok Nayak Jayprakash Hospital in New Delhi. In addition, Dr. Khatri has also obtained a Diplomate of the National Board (DNB) title in Medical Oncology through the Rajiv Gandhi Cancer Institute in Delhi.

While pursuing his professional qualifications, Dr. Khatri served as Senior Resident in the Department of Medicine at the Lok Nayak Hospital and Guru Teg Bahadur Hospital in New Delhi. During the course of completing his DNB, he spent three years as Resident at the Rajiv Gandhi Cancer Institute and Research Centre, and a further six months there as Assistant Consultant (Medical Oncology). He then was posted as a Consultant in Medical Oncology at the SMH-Curie Cancer Centre in New Delhi for a year, before he moved to the BL Kapur Hospital, designated as Senior Consultant in Medical Oncology. After gaining vital experience there, he returned to the SMH-Curie Cancer Centre, where he is currently attached.

Dr. Sameer Khatri has participated in several research studies and clinical trials as Principal Investigator. His articles and papers have been published in various medical journals of repute, and quite a few of his contributions have been presented at medical conferences connected to his field. He also had one of his papers selected for presentation at the... [+]


Appointment Information

SMH Curie Cancer Centre  New Delhi
09:00AM to 05:00PM
09:00AM to 05:00PM
09:00AM to 05:00PM
09:00AM to 05:00PM
09:00AM to 05:00PM
09:00AM to 05:00PM
Shanti Mukand Hospital, Vikas Marg Extension, Dayanand Vihar, Karkardooma, New Delhi - 110092
Tel: (011) 33669999
  • Lab
  • CT Scan
  • PET Scan
  • Radiation Facilities
  • Surgery
  • Medical Oncology

Ask Me

(Ask a specific question regarding your health issues, which may be answered by Dr. Sameer Khatri.)

I agree to be contacted on the mobile number and/or email id provided by me in Ask Me section.

Phase IV Clinical Trial - A retrospective evaluation of efficacy and safety of chemotherapeutic formulations of Fresenius kabi Oncology (Gemcitabine, Docetaxel, Irinotecan, Oxaliplation and Paclitaxel versus historical data in CRC, SCCHN, NSCLC, pancreatic carcinoma, gastric adenocarcinoma). [Principal Investigator]
Phase II Trial of Bavituximab plus Docetexel in patients with previously treated locally advanced or metastatic non- squamous non-small cell lung cancer. [Principal Investigator]
A randomised, multi-centre, double-blind, parallel group study to compare the pharmacokinetics, pharmacodynamics, safety and efficacy of two anti-CD20 monoclonal antibodies in combination with CHOP in patients with CD20-positive diffuse large B-cell lymphoma. [Principal Investigator]

Spontaneous rupture of hepatic hydatid cyst causing IVC thrombosis. Indian Journal of Gastroenterology. 1999; 18: 34.
Tuberculous mediastinitis - A rare presentation. Indian Journal of Chest Dis. Allied Sci. 1999; 4: 47-50.
Role of Tumour Necrosis Factor alfa (TNF alfa) and Interleukin 2 (IL 2) in pus aspirate and blood in patients with amoebic liver abscess. Journal of Association of Physicians of India. 1999; 47: 1065-67.


MBBS: Maulana Azad Medical College and associated Lok Nayak Jayprakash Hospital, New Delhi. 1991-94.
MD (General Medicine): Maulana Azad Medical College and associated Lok Nayak Jayprakash Hospital, New Delhi. 1999.
DNB (Medical Oncology): Rajiv Gandhi Cancer Institute and Research Centre, New Delhi. 2006.